Log in

Protagonist Therapeutics SEC Filings & 10K Form (NASDAQ:PTGX)

$10.81
-0.74 (-6.41 %)
(As of 10/13/2019 04:00 PM ET)
Today's Range
$10.77
Now: $10.81
$12.06
50-Day Range
$11.18
MA: $13.43
$16.07
52-Week Range
$5.49
Now: $10.81
$16.67
Volume180,301 shs
Average Volume160,669 shs
Market Capitalization$284.09 million
P/E RatioN/A
Dividend YieldN/A
Beta1.72

SEC Filings

Protagonist Therapeutics (NASDAQ:PTGX) SEC Filings

DateFilerForm TypeView
08/08/2019
5:17 PM
Liu David Y (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
5:15 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
4:21 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
8:29 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
3:49 PM
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G
06/17/2019
3:05 PM
Protagonist Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G
06/13/2019
3:02 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2019
5:33 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:31 PM
Protagonist Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:29 PM
Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:28 PM
Noonberg Sarah B. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:26 PM
KHOSLA CHAITAN PHD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
5:20 PM
Giraudo Bryan (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
6:40 PM
Kalkofen Donald A. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
6:35 PM
Kalkofen Donald A. (Reporting)
Protagonist Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2019
3:49 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2019
5:43 PM
Protagonist Therapeutics (Issuer)
Saks Samuel R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
3:32 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
6:08 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
6:04 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
4:27 PM
Protagonist Therapeutics (Filer)
Form DEFA14A
04/26/2019
4:25 PM
Protagonist Therapeutics (Filer)
Form DEF 14A
04/02/2019
6:19 PM
Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
6:16 PM
KHOSLA CHAITAN PHD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2019
3:01 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
7:52 PM
Protagonist Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2019
3:26 PM
Protagonist Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2019
3:06 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
5:35 PM
Liu David Y (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:33 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:32 PM
Protagonist Therapeutics (Issuer)
Saks Samuel R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:29 PM
Protagonist Therapeutics (Issuer)
Shames Richard S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
5:27 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
3:18 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
02/13/2019
12:44 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
02/08/2019
4:37 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:30 PM
Liu David Y (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
4:27 PM
Protagonist Therapeutics (Issuer)
Shames Richard S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
12:09 PM
CANAAN X L.P. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
01/16/2019
5:42 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
7:29 PM
Murphy Niall (Reporting)
Protagonist Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/14/2019
6:00 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2019
5:08 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/31/2018
3:20 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2018
7:30 AM
PERCEPTIVE ADVISORS LLC (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G
11/27/2018
3:29 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
3:57 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2018
3:28 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2018
7:37 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2018
4:26 PM
Protagonist Therapeutics (Filer)
Form 424B3
09/23/2018
11:16 PM
Protagonist Therapeutics (Filer)
Form EFFECT
09/06/2018
8:43 PM
Protagonist Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/17/2018
7:29 PM
O'Neil Thomas P. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2018
7:28 PM
Protagonist Therapeutics (Issuer)
Shames Richard S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2018
7:25 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2018
7:22 PM
Liu David Y (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2018
3:40 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
08/07/2018
4:30 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2018
5:07 AM
Protagonist Therapeutics (Filer)
Form 424B5
08/07/2018
5:01 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2018
6:23 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2018
5:36 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2018
3:04 PM
GREAT POINT PARTNERS LLC (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G
06/12/2018
5:55 PM
Protagonist Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
5:52 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
5:50 PM
Protagonist Therapeutics (Issuer)
Shanafelt Armen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
5:48 PM
Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
5:43 PM
Noonberg Sarah B. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
5:40 PM
KHOSLA CHAITAN PHD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
5:39 PM
Giraudo Bryan (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
5:29 PM
Protagonist Therapeutics (Issuer)
Saks Samuel R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
5:14 PM
Protagonist Therapeutics (Issuer)
Saks Samuel R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/31/2018
4:06 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2018
4:29 PM
Protagonist Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/24/2018
3:47 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G
05/21/2018
3:34 PM
Canaan Partners X LLC (Reporting)
CANAAN X L.P. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
4:48 PM
Giraudo Bryan (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2018
4:43 PM
Giraudo Bryan (Reporting)
Protagonist Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/16/2018
4:16 PM
Canaan Partners X LLC (Reporting)
CANAAN X L.P. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2018
7:07 AM
Protagonist Therapeutics (Filer)
Form DEFA14A
05/16/2018
7:05 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2018
5:50 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2018
3:38 PM
Protagonist Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2018
3:19 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2018
3:14 PM
Protagonist Therapeutics (Filer)
Form DEFA14A
04/18/2018
3:05 PM
Protagonist Therapeutics (Filer)
Form DEF 14A
03/28/2018
4:20 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2018
3:25 PM
Canaan Partners X LLC (Reporting)
CANAAN X L.P. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2018
5:49 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2018
4:33 PM
Canaan Partners X LLC (Reporting)
CANAAN X L.P. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2018
4:22 PM
Canaan Partners X LLC (Reporting)
CANAAN X L.P. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2018
6:26 PM
Noonberg Sarah B. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4/A
03/15/2018
3:55 PM
Canaan Partners X LLC (Reporting)
CANAAN X L.P. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
3:48 PM
Liu David Y (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2018
4:02 PM
Protagonist Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/07/2018
3:36 PM
Protagonist Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/02/2018
6:26 PM
Protagonist Therapeutics (Issuer)
Shames Richard S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
6:23 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
6:20 PM
O'Neil Thomas P. (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
6:17 PM
Liu David Y (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel